PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
13-Jan-2020 Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery Exscientia
13-Jan-2020 SP Scientific launches the HT Series 3i Evaporators SP Scientific
13-Jan-2020 Yposkesi selected to produce clinical and large-scale commercial material of micro-dystrophin for Genethon and Sarepta Therapeutics program Yposkesi
13-Jan-2020 Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio Calibre Scientific
13-Jan-2020 PharmaLex strengthens Healthcare Compliance services PharmaLex GmbH
13-Jan-2020 Hansa Biopharma provides business update ahead of the JP Morgan Global Healthcare Conference Hansa Biopharma
13-Jan-2020 Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe Inflazome
13-Jan-2020 Data monitoring committee approves initiation of expansion cohort in colorectal cancer patients Faron Pharmaceuticals
13-Jan-2020 Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility to provide advanced extracellular vesicles-focused analytical services NanoFCM
13-Jan-2020 Acquisition of Ashfield Pharmacovigilance Inc., a US pharmacovigilance services provider, from UDG Healthcare for $10 million Ergomed plc
10-Jan-2020 Evotec & Scynexis to lead the workshops for Superbugs & Superdrugs 2020 SMi Group
10-Jan-2020 ELASMOGEN SECURES £2 M FUNDING Elasmogen Ltd
10-Jan-2020 NBE-Therapeutics Closes USD 22M Series C Financing Round NBE-Therapeutics AG
10-Jan-2020 Glauconix Biosciences Promotes Kimberly Southern to the Position of Chief Executive Officer Glauconix Biosciences Inc
10-Jan-2020 Galen, an Almac Group Company, Announces Completion of Multi-Million Pound POA Pharma Acquisition Almac Group
10-Jan-2020 ProBioGen Inks Next Commercial GlymaxX® License with Roche ProBioGen
10-Jan-2020 BC Platforms Partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers BC Platforms
10-Jan-2020 HUMMINGBIRD BIOSCIENCE PUBLISHES PRECLINICAL DATA DEMONSTRATING EFFICACY OF HMBD-001 IN HER3 DRIVEN CANCERS Hummingbird Bioscience
10-Jan-2020 NANOBIOTIX ANNOUNCES PLAN FOR GLOBAL PHASE III HEAD AND NECK CANCER REGISTRATION TRIAL ALONG WITH OVERALL DEVELOPMENT UPDATE NANOBIOTIX
10-Jan-2020 Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio Calibre Scientific